Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Free Cash Flow (2022 - 2025)

Core Laboratories (CLB) has 4 years of Free Cash Flow data on record, last reported at $6.5 million in Q3 2025.

  • For Q3 2025, Free Cash Flow rose 11.85% year-over-year to $6.5 million; the TTM value through Sep 2025 reached $37.1 million, down 30.66%, while the annual FY2024 figure was $43.4 million, 81.99% up from the prior year.
  • Free Cash Flow reached $6.5 million in Q3 2025 per CLB's latest filing, down from $10.4 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $26.3 million in Q4 2023 and bottomed at -$6.6 million in Q3 2023.
  • Average Free Cash Flow over 4 years is $7.8 million, with a median of $6.2 million recorded in 2022.
  • The widest YoY moves for Free Cash Flow: up 305.38% in 2023, down 212.41% in 2023.
  • A 4-year view of Free Cash Flow shows it stood at $20.2 million in 2022, then increased by 29.93% to $26.3 million in 2023, then plummeted by 38.29% to $16.2 million in 2024, then tumbled by 59.99% to $6.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were $6.5 million in Q3 2025, $10.4 million in Q2 2025, and $3.9 million in Q1 2025.